Michael McGuffin is stepping down as American Herbal Products Association president after more than 25 years and will transition into a senior advisor role following the appointment of a successor.
McGuffin Moving To Senior Advisor At AHPA After More Than 25 Years At Helm
AHPA’s significant legislative victories included enactment of Dietary Supplement and Nonprescription Drug Consumer Protection Act in 2006 to establish a serious adverse event reporting law for vitamin, mineral and supplement products.
More from Business
• By
While uncertainty might reign in the UK consumer health market - which grew by by 8% to £4.1bn ($5.3bn) in 2024 - “opportunity is everywhere” according to NielsenIQ health and beauty insights manager Alex Heffernan.
• By
Agreement with Seoul-based health and wellness player TopHealth will see the roll out of ProBiotix' cholesterol-lowering probiotics in South Korea.
• By
Italy's Alfasigma has expanded its operation in Germany with the creation of a new Consumer Healthcare unit. Led by Rüdiger Hoppe, the business is rolling out OTC medical devices and dietary supplements in the gastrointestinal category.
• By
Ibis Reproductive Health adds Desiree Williams to lead MORE Study; Radicle Science adds Rob Sinnott as senior strategic advisor; Leann Sims joins AbundaBox as COO; former Cannabis Beverage Association president moves to Vertosa; Vegamour expands executive staff with CMO; and Oura Ring firm appoints CMO.
More from HBW Insight
• By
Manufacturers, marketers and other businesses in the industry may be thinking, “Well, this is different” because the president ordered tariffs on a list of countries rather than on his sole first-term target of China.
• By
Energy and Commerce Health Subcommittee members, including several health care professionals, make clear their concerns about the US sunscreen market during hearing on reauthorizing FDA’s OMUFA program.
• By
Discussion of introducing additional OTC sunscreen ingredients escaped a total eclipse criticism of Trump’s health agency layoffs caused. Comments and questions by Republican members joined by several Democrats and focused testimony and answers by witnesses representing the industry and public health groups spotlighted sunscreen.